Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Globus Medical Inc shares valued at $1,250,770 were sold by Pfeil Keith W on Jan 10 ’25. At $88.29 per share, Pfeil Keith W sold 14,167 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Pfeil Keith W purchased 14,167 shares, netting a total of over 1,250,772 in proceeds.
Before that, Huller Kelly had sold 2,500 shares from its account. In a trade valued at $217,502, the SVP, GC, Corporate Secretary traded Globus Medical Inc shares for $87.00 each. Upon closing the transaction, the insider’s holdings decreased to 2,500 shares, worth approximately $0.0.
As published in a research note from BofA Securities on January 10, 2025, Globus Medical Inc [GMED] has been rated up from an Underperform to a Neutral and the price target has been revised to $97. Analysts at Morgan Stanley upgraded the stock from ‘”an Equal-weight”‘ to ‘”an Overweight”‘ outlook in a report released in early December. As of August 07, 2024, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for GMED. Earlier on May 20, 2024, Piper Sandler upgraded its rating. Their new recommendation was “an Overweight” for GMED stock which previously was a “a Neutral”.
Analyzing GMED Stock Performance
During the last five days, there has been a surge of approximately 5.83%. Over the course of the year, Globus Medical Inc shares have jumped approximately 12.83%. Shares of the company reached a 52-week high of $93.67 on 01/22/25 and a 52-week low of $81.37 on 01/02/25. A 50-day SMA is recorded $84.30, while a 200-day SMA reached $71.30. Nevertheless, trading volume fell to 1.04 million shares from 1.55 million shares the previous day.
Support And Resistance Levels for Globus Medical Inc (GMED)
According to the 24-hour chart, there is a support level at 92.04, which, if violated, would cause prices to drop to 90.75. In the upper region, resistance lies at 94.14. The next price resistance is at 94.95. RSI (Relative Strength Index) is 79.81 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 4.94, which suggests the price will increase in the coming days. Percent R is at 2.85%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
